Loki Therapeutics Announces Publication in Science Translational Medicine Demonstrating Potential of AWAKE-LM-TT as a Treatment for Pancreatic Cancer

/PRNewswire/ -- Loki Therapeutics, a company developing next-generation therapeutics that leverage vaccination recall antigens to enhance longevity and treat...

Related Keywords

Dave Schemelia ,Chris Bradley ,Claudia Gravekamp ,Us Food Drug Administration ,Albert Einstein College Of Medicine ,Loki Co ,Albert Einstein College ,Loki Therapeutics ,Associated Professor ,Albert Einstein School ,Toxoid Protein ,Pancreatic Tumors ,Induces Cancer Cell Death ,Investigational New Drug ,Drug Administration ,Listeria Monocytogenes ,